Amgen reported $24.38B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
ALKERMES ALKS:US 1.05B 15.25M
Amgen AMGN:US $ 24380M 5281M
Astrazeneca AZN:US 26.69B 583M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Exelixis EXEL:US $ 1662.03M 68.78M
Genmab GEN:DC 21.95B 1.65B
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Glaxosmithkline GSK:US $ 18254M 688M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NVS:US $ 26253M 2445M
Novartis NOVN:VX 26.25B 2.45B
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Takeda 4502:JP Y 2456353M 20105M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
YTE INCY:US $ 2923.8M 303.74M